[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100480312":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":25,"centralContacts":30,"locations":39,"responsibleParty":57,"collaborators":59,"id":62,"slug":10,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":63,"sex":69,"minAge":70,"maxAge":10,"enrollmentInfo":71,"targetDuration":10,"studyType":74,"phases":10,"briefSummary":75,"conditions":76,"keywords":78,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Juvenile Idiopathic Arthritis",null,"Patients seen in a specialized rheumatology consultation for the management of juvenile idiopathic arthritis in an adult service, after information and collection of their non-opposition.",[13,14],"Biological: Blood sample","Biological: Joint puncture",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"BIOLOGICAL","Blood sample","Addtional tube of blood needed for follow up of patients",[9],{"type":17,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"Joint puncture","Joint puncture if needed according to routine care of the patients",[9],[26],{"name":27,"affiliation":28,"role":29},"Yannick ALLANORE, PD, PhD","Cochin Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP)","PRINCIPAL_INVESTIGATOR",[31,35],{"name":27,"role":32,"phone":33,"phoneExt":10,"email":34},"CONTACT","0033158412563","yannick.allanore@aphp.fr",{"name":36,"role":32,"phone":37,"phoneExt":10,"email":38},"Marie BENHAMMANI-GODARD","+33 1 58411190","marie.godard@aphp.fr",[40],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Rheumatology Department, Cochin Hospital","RECRUITING","Paris","IDF","75014","France",{"type":48,"coordinates":49},"Point",[50,51],2.3488,48.85341,{"lat":51,"lon":50},[54],{"name":55,"role":32,"phone":56,"phoneExt":10,"email":34},"Yannick ALLANORE, MD, PhD","0033158412572",{"type":58,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[60],{"name":61,"class":6},"URC-CIC Paris Descartes Necker Cochin","100480312",false,"NCT05534347","Angiogenic Biomarkers in Juvenile Idiopathic Arthritis","Angiogenic Inflammatory Biomarkers in Juvenile Idiopathic Arthritis","MAJIC","Inclusion Criteria:\n\n* Greater than or equal to 16 years-old\n* Diagnosis of Juvenile Idiopathic Arthritis with specialized follow up in Rheumatology at Cochin Hospital\n* No-opposition to the research\n* Patient with health insurance\n* Mastery of the French language\n\nExclusion Criteria:\n\n* Patient under curatorship or guardianship\n* Patient receiving french state medical aid","ALL","16 Years",{"count":72,"type":73},300,"ESTIMATED","OBSERVATIONAL","The aim of the study is to determine whether serum inflammatory angiogenic markers (eg, semaphorins, CCN1) predict severity of juvenile idiopathic arthritis defined by structural progression and\u002For therapeutic escalation.",[77],"Juvenile Idiopathic Arthritis (JIA)",[79,80,81,82,83,84,85,86],"Juvenile idiopathic arthritis (JIA)","JIA patients in transition towards adult ward","Prognosis of JIA","Severity and structural damage in JIA","Angiogenic and inflammatory biomarkers","Semaphorin (SEMA4A), CCN1","Serum fluid","Synovial fluid","2025-09-05",{"date":89,"type":90},"2025-09-12","ACTUAL",{"date":92,"type":90},"2023-03-13",{"date":94,"type":73},"2030-03",{"name":5,"class":6},1]